2136630-26-5

2136630-26-5 structure

Name: Telitacicept
Chemical Name: Telitacicept
CAS Number: 2136630-26-5
Molecular Formula: C₄₄H₂₆I₄N₄
Molecular Weight: 1118.3
Catalog: Research Areas Inflammation/Immunology
Create Date: 2023-01-15 08:46:01
Modify Date: 2025-08-26 13:26:23
Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease[1].

Name	Telitacicept

Description	Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
Target	(BLyS)/APRIL[1]
References	[1]. Yao X, et, al. Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis. Eur J Pharm Sci. 2021 Apr 1;159:105704.